Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to ronran's message

If Alliacense remains, they hold all the cards. The PDS agreement with Alliacense from 2012 allows Alliacense to break the agreement EXCLUSIVELY. PDS and PTSC have no way to break the commercialization agreement without Alliacense consent. It doesn't matter how poorly they perform, which is something they are well versed at. I suggest you check your 10K filings and the Debtor disclosure statement to see if I'm correct.

The BK court can nullify the Alliacense agreement, which is what Moore wants to do. Alliacense is the key. Get rid of Alliacense, and you get rid of Leckrone.

What I don't understand is why PTSC didn't use this leverage to come up with something better than the Joint Plan. All they've managed to do is negotiate a worse agreement than the two before it!

Please login to post a reply
OutsideGuy
City
Rank
Mail Room
Activity Points
124
Rating
Your Rating
Date Joined
09/05/2014
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post